Search Results

There are 7847 results for: content related to: Lymphocytic colitis secondary to ipilimumab treatment

  1. You have full text access to this OnlineOpen article
    CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations

    Cancer Medicine

    Luis H. Camacho

    Article first published online : 25 JAN 2015, DOI: 10.1002/cam4.371

  2. You have free access to this content
    Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab

    Cancer

    Volume 119, Issue 9, 1 May 2013, Pages: 1675–1682, Jeffrey S. Weber, Reinhard Dummer, Veerle de Pril, Celeste Lebbé, F. Stephen Hodi and for the MDX010-20 Investigators

    Article first published online : 7 FEB 2013, DOI: 10.1002/cncr.27969

  3. You have full text access to this OnlineOpen article
    Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

    Annals of the New York Academy of Sciences

    Volume 1291, Issue 1, July 2013, Pages: 1–13, Jedd D. Wolchok, F. Stephen Hodi, Jeffrey S. Weber, James P. Allison, Walter J. Urba, Caroline Robert, Steven J. O'Day, Axel Hoos, Rachel Humphrey, David M. Berman, Nils Lonberg and Alan J. Korman

    Article first published online : 17 JUN 2013, DOI: 10.1111/nyas.12180

  4. You have full text access to this OnlineOpen article
    Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting

    Cancer

    Volume 116, Issue 7, 1 April 2010, Pages: 1767–1775, Geoffrey Y. Ku, Jianda Yuan, David B. Page, Sebastian E. A. Schroeder, Katherine S. Panageas, Richard D. Carvajal, Paul B. Chapman, Gary K. Schwartz, James P. Allison and Jedd D. Wolchok

    Article first published online : 8 FEB 2010, DOI: 10.1002/cncr.24951

  5. You have full text access to this OnlineOpen article
    Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 106–117, Yan Feng, Eric Masson, David Dai, Susan M. Parker, David Berman and Amit Roy

    Article first published online : 20 JUN 2014, DOI: 10.1111/bcp.12323

  6. You have full text access to this OnlineOpen article
    Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery

    Cancer Medicine

    Volume 4, Issue 1, January 2015, Pages: 1–6, Karim Tazi, Amanda Hathaway, Cody Chiuzan and Keisuke Shirai

    Article first published online : 27 AUG 2014, DOI: 10.1002/cam4.315

  7. You have full text access to this OnlineOpen article
    Ipilimumab and radiation therapy for melanoma brain metastases

    Cancer Medicine

    Volume 2, Issue 6, December 2013, Pages: 899–906, Ann W. Silk, Michael F. Bassetti, Brady T. West, Christina I. Tsien and Christopher D. Lao

    Article first published online : 10 OCT 2013, DOI: 10.1002/cam4.140

  8. You have free access to this content
    Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4)

    Cancer

    Volume 110, Issue 12, 15 December 2007, Pages: 2614–2627, Steven J. O'Day, Omid Hamid and Walter J. Urba

    Article first published online : 14 NOV 2007, DOI: 10.1002/cncr.23086

  9. Molecularly targeted therapies for melanoma

    International Journal of Dermatology

    Volume 52, Issue 5, May 2013, Pages: 523–530, Lucinda S. Liu and Oscar R. Colegio

    Article first published online : 17 APR 2013, DOI: 10.1111/j.1365-4632.2012.05829.x

  10. You have free access to this content
    Clinical activity of ipilimumab for metastatic uveal melanoma

    Cancer

    Volume 119, Issue 20, 15 October 2013, Pages: 3687–3695, Jason J. Luke, Margaret K. Callahan, Michael A. Postow, Emanuela Romano, Nikhil Ramaiya, Mark Bluth, Anita Giobbie-Hurder, Donald P. Lawrence, Nageatte Ibrahim, Patrick A. Ott, Keith T. Flaherty, Ryan J. Sullivan, James J. Harding, Sandra D'Angelo, Mark Dickson, Gary K. Schwartz, Paul B. Chapman, Jedd D. Wolchok, F. Stephen Hodi and Richard D. Carvajal

    Article first published online : 2 AUG 2013, DOI: 10.1002/cncr.28282

  11. You have free access to this content
    Update on monoclonal antibodies for the treatment of cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 7, Issue s1, April 2011, Pages: 20–25, Ian D DAVIS

    Article first published online : 24 MAR 2011, DOI: 10.1111/j.1743-7563.2011.01384.x

  12. You have full text access to this OnlineOpen article
    Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?

    Cancer Medicine

    Volume 2, Issue 2, April 2013, Pages: 243–252, Edward Cha and Eric J. Small

    Article first published online : 24 FEB 2013, DOI: 10.1002/cam4.64

  13. You have free access to this content
    Ipilimumab-induced toxicities and the gastroenterologist

    Journal of Gastroenterology and Hepatology

    Accepted manuscript online: 16 JAN 2015, Robert Cheng, Adam Cooper, James Kench, Geoff Watson, William Bye, Catriona McNeil and Nicholas Shackel

    DOI: 10.1111/jgh.12888

  14. Melanoma Immunotherapy

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 6, November/December 2010, Pages: 620–642, Shanthi Sivendran, Bradley Glodny, Michael Pan, Miriam Merad and Yvonne Saenger

    Article first published online : 23 NOV 2010, DOI: 10.1002/msj.20215

  15. You have free access to this content
    Novel antibodies targeting immune regulatory checkpoints for cancer therapy

    British Journal of Clinical Pharmacology

    Volume 76, Issue 2, August 2013, Pages: 233–247, Chern Siang Lee, Mark Cragg, Martin Glennie and Peter Johnson

    Article first published online : 23 JUL 2013, DOI: 10.1111/bcp.12164

  16. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy

    Immunological Reviews

    Volume 224, Issue 1, August 2008, Pages: 141–165, Karl S. Peggs, Sergio A. Quezada and James P. Allison

    Article first published online : 4 AUG 2008, DOI: 10.1111/j.1600-065X.2008.00649.x

  17. You have free access to this content
    Society for Melanoma Research 2014 Congress

    Pigment Cell & Melanoma Research

    Volume 27, Issue 6, November 2014, Pages: 1169–1241,

    Article first published online : 23 OCT 2014, DOI: 10.1111/pcmr.12317

  18. Developing melanoma therapeutics: overview and update

    Wiley Interdisciplinary Reviews: Systems Biology and Medicine

    Volume 5, Issue 3, May/June 2013, Pages: 257–271, John B. Korman and David E. Fisher

    Article first published online : 13 FEB 2013, DOI: 10.1002/wsbm.1210

  19. You have free access to this content
    Immunotherapy of cancer in 2012

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 309–335, John M. Kirkwood, Lisa H. Butterfield, Ahmad A. Tarhini, Hassane Zarour, Pawel Kalinski and Soldano Ferrone

    Article first published online : 10 MAY 2012, DOI: 10.3322/caac.20132

  20. Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents

    Clinical Pharmacology & Therapeutics

    Volume 96, Issue 4, October 2014, Pages: 449–457, R Donald Harvey and E T Morgan

    Article first published online : 2 JUL 2014, DOI: 10.1038/clpt.2014.143